Effects of CC chemokine receptor 5 (CCR5) inhibitors on the dynamics of CCR5 and CC-chemokine-CCR5 interactions

被引:4
|
作者
Nakata, Hirotomo [1 ,2 ,3 ]
Kruhlak, Michael [4 ]
Kamata, Wakako [2 ,3 ]
Ogata-Aoki, Hiromi [2 ,3 ]
Li, Jianfeng [5 ,6 ]
Maeda, Kenji [1 ]
Ghosh, Arun K. [5 ,6 ]
Mitsuya, Hiroaki [1 ,2 ,3 ]
机构
[1] NCI, Expt Retrovirol Sect, HIV & AIDS Malignancy Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA
[2] Kumamoto Univ, Sch Med, Dept Hematol, Kumamoto 860, Japan
[3] Kumamoto Univ, Sch Med, Dept Infect Dis, Kumamoto 860, Japan
[4] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA
[5] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA
[6] Purdue Univ, Dept Med Chem, W Lafayette, IN 47907 USA
基金
美国国家卫生研究院;
关键词
R5; HIV-1; INFECTION; SMALL-MOLECULE; CORECEPTOR CCR5; MIP-1; ALPHA; ANTAGONIST; RANTES; ENTRY; MARAVIROC; FUSION; POTENT;
D O I
10.3851/IMP1529
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: This study aimed to examine how CC chemokine receptor 5 (CCR5) inhibitors (aplaviroc [APL], TAK779 and maraviroc [MVC]) interact with CCR5 and affect its dynamics and physiological CC-chemokine-CCR5 interactions. Methods: A yellow fluorescent protein (YFP)-tagged CCR5-expressing U373-MAGI cell line was generated and a stable CCR5-expressing clonal population, (YFP)CCR5-UM16, was prepared. (YFP)CCR5-UM16 cells were exposed to RANTES, macrophage inflammatory protein (MIP)-1 alpha or MIP-1 beta (all 100 ng/ml) with or without CCR5 inhibitors and (YFP)CCR5 internalization was visualized with real-time by laser scanning confocal microscopy. The mobility of (YFP)CCR5 was also examined in the presence of CCR5 inhibitors with fluorescence recovery after photobleaching (FRAP) imaging. Results: Following the addition of each CC chemokine, intracellular fluorescence intensity increased whereas membranous fluorescence decreased, signifying (YFP)CCR5 internalization. All three CCR5 inhibitors failed to induce (YFP)CCR5 internalization. All three CCR5 inhibitors blocked the CC-chemokine-induced internalization at a high concentration of 1 mu M; however, the ratio of APL concentration that blocked RANTES-induced internalization by 50% over APL concentration that blocked HIV type-1 (HIV-1) replication by 50% was 16.4, indicating that APL permits CC-chemokine-induced internalization to a much greater extent compared with TAK779 and MVC, having ratios of 1.1 and 0.9, respectively. The examination of (YFP)CCR5 mobility with FRAP imaging revealed that (YFP)CCR5 continuously underwent rapid redistribution, which none of the three inhibitors blocked. Conclusions: The finding that APL moderately blocked the RANTES-triggered (YFP)CCR5 internalization despite the highly potent anti-HIV-1 activity of APL strongly suggests that development of CCR5 inhibitors, which do not overly inhibit physiological CC-chemokine-CCR5 interactions, is practically feasible.
引用
收藏
页码:321 / 331
页数:11
相关论文
共 50 条
  • [1] Chemokine-induced phosphorylation of CC chemokine receptor 5 (CCR5)
    Olbrich, H
    Proudfoot, AEI
    Oppermann, M
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (03) : 281 - 285
  • [2] Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus
    Oppermann, M
    Mack, M
    Proudfoot, AEI
    Olbrich, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (13) : 8875 - 8885
  • [3] Paleogenomic variation in a CC Chemokine Receptor Gene (CCR5)
    Hoover, Kara C.
    [J]. AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY, 2014, 153 : 144 - 144
  • [4] The chemokine receptor, CCR5
    Mueller, A
    Strange, PG
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (01): : 35 - 38
  • [5] CC chemokine receptor 5 (CCR5) mRNA expression in pulmonary sarcoidosis
    Petrek, M
    Gibejova, A
    Drabek, J
    Mrazek, F
    Kolek, V
    Weigl, E
    du Bois, RM
    [J]. IMMUNOLOGY LETTERS, 2002, 80 (03) : 189 - 193
  • [6] The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection
    Abdi, R
    Smith, RN
    Makhlouf, L
    Najafian, N
    Luster, AD
    Auchincloss, H
    Sayegh, MH
    [J]. DIABETES, 2002, 51 (08) : 2489 - 2495
  • [7] Allosteric Model of Maraviroc Binding to CC Chemokine Receptor 5 (CCR5)
    Garcia-Perez, Javier
    Rueda, Patricia
    Alcami, Jose
    Rognan, Didier
    Arenzana-Seisdedos, Fernando
    Lagane, Bernard
    Kellenberger, Esther
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (38) : 33409 - 33421
  • [8] Gene organization and promoter function for CC chemokine receptor 5 (CCR5)
    Guignard, F
    Combadiere, C
    Tiffany, HL
    Murphy, PM
    [J]. JOURNAL OF IMMUNOLOGY, 1998, 160 (02): : 985 - 992
  • [9] Association of the CC chemokine receptor 5 (CCR5) polymorphisms with preeclampsia in Turkish women
    Figen Gurdol
    Leman M. Yurdum
    Ummühan Ozturk
    Elif Isbilen
    Bedia Cakmakoglu
    [J]. Archives of Gynecology and Obstetrics, 2012, 286 : 51 - 54
  • [10] Association of the CC chemokine receptor 5 (CCR5) polymorphisms with preeclampsia in Turkish women
    Gurdol, Figen
    Yurdum, Leman M.
    Ozturk, Ummuhan
    Isbilen, Elif
    Cakmakoglu, Bedia
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 286 (01) : 51 - 54